• Profile
Close

Platelet rich plasma in patients with partial thickness rotator cuff tears or tendinopathy leads to significantly improved short-term pain relief and function compared to corticosteroid injection: a double-blind randomized controlled trial

Arthroscopy Oct 30, 2020

Kwong CA, Woodmass JM, Gusnowski EM, et al. - A randomized controlled trial was designed to compare platelet-rich plasma (PRP) with a standard corticosteroid (CS) in providing pain relief and improved function in patients with rotator cuff tendinopathy and partial-thickness rotator cuff tears (PTRCT). The trial included individuals with ultrasound or MRI proven PTRCT to either an ultrasound-guided PRP or CS injection. A total of 99 patients (47 in the PRP and 52 in the CS groups) were included. After both ultrasound-guided CS and PRP injections, patients with PTRCTs or tendinopathy experienced a clinical improvement in pain and patient-reported outcome scores. At short-term follow-up (3 months), individuals who received PRP obtained superior improvement in pain and function. No sustained benefit of PRP over CS was reported at longer-term follow-up (12 months).

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay